There is paucity of data regarding the outcomes of hospitalized acute pulmonary embolism
(PE) patients with heart failure (HF) and Coronavirus Disease 2019 (COVID‐19) infection …

PURPOSE: The study aimed to assess the incidence of COVID-19 infection among
hospitalizations for pulmonary embolism (PE). The study also evaluated in-hospital …

Background There is a paucity of data on the impact of COVID-19 pandemic on the
management and outcomes of acute pulmonary embolism (PE). Methods We identified …

Pulmonary embolism (PE) in the setting of COVID-19 is related to the procoagulant state as
evidenced by the increased D-dimer levels and in situ thrombosis [1, 2] and it usually …

Background Pulmonary embolism (PE) is a complication that can occur in individuals with
COVID-19 because of the inherent thrombogenic risk. Systemic thrombolysis and …

Background Mortality in critically ill COVID (coronavirus disease) patients secondary to
pulmonary embolism (PE) has conflicting data. We aim to evaluate the mortality outcomes of …

PURPOSE: Coronavirus disease 2019 (COVID-19) leads to a hypercoagulable state and is
associated with an increased risk of venous thromboembolism. While it is known that COVID …

Background COVID-19-related acute pulmonary thromboembolism (APE) is associated with
poor outcomes in patients with COVID-19. There are studies investigating the association …

There is an increased risk of venous thromboembolism among patients with COVID-19
infection, with the risk being higher among those needing the intensive level of care. Existing …

Background: Pulmonary embolism (PE) has been noted in acute COVID infection. However,
it is unclear if patients with prior COVID share the same poor outcomes as those with active …